Vanguard Capital Management
IDYA icon

Vanguard Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Vanguard Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154M Buy
4,132,646
+400,224
+11% +$12.3M ﹤0.01% 1307
2026
Q1 		$124M Buy
+3,732,422
New +$125M ﹤0.01% 1348

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management's IDYA Position: Q2 2026 in Review

Vanguard Capital Management increased its IDEAYA Biosciences (IDYA) stake by 11% in Q2 2026, buying an estimated $12.3M and bringing the position to 4,132,646 shares worth $154M. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

Vanguard Capital Management first reported a position in IDYA in Q1 2026 and has held it in 2 quarters since. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Vanguard Capital Management held 4,132,646 shares of IDEAYA Biosciences worth $154M as of Q2 2026.
  • Vanguard Capital Management bought 400,224 IDEAYA Biosciences shares in Q2 2026, an estimated $12.3M.
  • IDEAYA Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1307 holding.
  • Vanguard Capital Management first reported a position in IDEAYA Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.